We have established a reconstitution system for the translocon SecYEG in proteoliposomes in which 55% of the accessible translocons are active. This level corresponds to the fraction of translocons that are active in vitro when assessed in their native environment of cytoplasmic membrane vesicles. Assays using these robust reconstituted proteoliposomes and cytoplasmic membrane vesicles have revealed that the number of SecYEG units involved in an active translocase depends on the precursor undergoing transfer. The active translocase for the precursor of periplasmic galactose-binding protein contains twice the number of heterotrimeric units of SecYEG as does that for the precursor of outer membrane protein A.
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SecA | SecB | secretion | export L ocalization of specific polypeptides that involves transfer across biological membranes is a ubiquitous process. In all three domains of life, the component of the membrane translocon that provides the channel through the membrane is highly conserved [Sec61α in eukaryotes and SecY in archaea and eubacteria (1) ]. In Escherichia coli, the general secretory (Sec) system comprises two heterotrimeric integral membrane complexes: SecY, SecE, and SecG (SecYEG) and SecD, SecF, and YajC (SecDF/YajC) (2) . The Sec system translocates proteins before they acquire stable, tertiary structure (3), and thus, in addition to a pathway through the membrane, the system includes cytosolic factors such as SecA and SecB, which act as chaperones to maintain newly synthesized polypeptides in a state compatible with transfer (4) . SecA in complex with precursor polypeptides, with or without SecB, delivers polypeptides to the membrane Sec translocon. At the membrane, SecA binds SecY and acts as a motor providing energy from a cycle of binding and hydrolysis of ATP to move precursors through the channel in SecY. In vivo proton-motive force is also coupled to translocation via SecDF/YajC (5, 6 ). An active translocase consists of the two integral membrane heterotrimeric complexes and the motor SecA ATPase, which is considered a peripheral subunit. Since the original discovery of SecA (7), it has been known that the protein is distributed in vivo equally between the cytosol and the membrane. Numerous early studies demonstrated that SecA is not simply associated with the membrane translocon via protein-protein interaction, but rather, in vivo, as much as 30% of membraneassociated SecA is integral to the membrane and is resistant to removal by high-salt and urea washes (8) (9) (10) (11) (12) (13) . A specific role has not yet been assigned to the integral SecA.
SecA is a dynamic, multidomain protein that undergoes structural changes during the cycle of export. The best-characterized of the changes are those associated with regulation of the ATPase activity that involve alteration of interactions among the intramolecular regulator of ATPase 1 (IRA1) motif and the two nucleotide binding domains (for structure, see Fig. S1 ). Conformational changes are induced by interaction of SecA both with proteins and with membrane lipids (2) . An elegant study using a low level of denaturant to shift SecA into a state exhibiting the fully activated level of translocation ATPase allowed studies of SecA in a soluble state that would not have been possible in the presence of lipids (14) . It was shown that several domain-domain interfaces were disrupted and that the C-terminal 30-kDa region became restructured. Not only does SecA change when it binds the translocon, but there are reciprocal conformational changes in SecY, as revealed in two X-ray structures of complexes (15, 16) . The C-terminal transmembrane (TM) helices TM6 through TM10 shift their positions to open the structure. These conformational changes in the translocase underlie the mechanism.
Two major barriers obstruct a more detailed description of the complex cycle of translocation: lack of knowledge of the role in vivo of the integrally associated SecA and the unanswered question of the stoichiometry of the components of a functioning translocase. It is clear that the channel for transfer of polypeptides lies within a monomer of SecY (1, (15) (16) (17) (18) ; however, SecYEG exists as monomers, dimers, and higher oligomers (19) (20) (21) (22) (23) (24) . Therefore, much controversy has arisen surrounding the question of whether the active translocase comprises a SecYEG monomer or dimer (17, (25) (26) (27) (28) . One idea is that an idle unit of SecYEG might be involved in stabilizing the translocase, perhaps through binding to SecA (17, 25, 26) .
Our study addresses both issues. We established a reconstituted translocase in which SecYEG is rendered highly active by assembly into liposomes in the presence of SecA. The effect of this coassembly has implications for the importance of the integral membrane SecA found in vivo. Furthermore, using this system we revealed a difference in the number of units of SecYEG between the translocase exporting outer membrane protein A (OmpA) and that used for periplasmic galactose-binding protein (GBP).
Results
We developed a proteoliposome preparation intended to mimic the situation in vivo, in which SecA is integrally associated with the cytoplasmic membrane. Unilamellar liposomes were prepared by the extrusion of E. coli polar lipids through a porous membrane. The detergent, β-dodecylmaltoside, was then added to a concentration determined to swell, but not disrupt, the liposomes. Proteins, either SecYEG alone or SecYEG and SecA, were added in detergent, and the detergent subsequently was removed (Supporting Information). Liposomes containing SecYEG assembled in the presence of SecA will be referred to as proteoliposomes SecYEG•A (PLYEG•A) and those containing SecYEG only as PLYEG.
The two types of proteoliposomes were subjected to assays for translocation using two authentic radiolabeled ligands: the precursor of OmpA and the precursor of GBP. Proteoliposomes in which SecYEG was assembled in the presence of SecA showed threefold increases in the final level of translocation of both proOmpA and pGBP compared with the activity of proteoliposomes to which SecA was added during the assay (Fig. 1) .
We considered three possibilities to explain the high activity of PLYEG•A: assembly into liposomes of SecYEG in complex with SecA might result in an increase in the number of translocons oriented with the cytoplasmic face accessible, the number of translocons that are active might increase, or the rate constant of each translocon might increase.
Determination of Orientation of SecYEG. To determine the orientation of SecY in our proteoliposomes, we introduced a nitroxide spin label via a single cysteine placed in the cytoplasmic loop 6/7 at position 255. The nitroxide was coupled to the cysteine residue through a disulfide bond, allowing release by addition of a reducing agent. Treatment of the proteoliposomes with 50 μM tris (2-carboxyethyl)phosphine (TCEP), which does not penetrate the membrane at this low concentration, released 55% of the spin label relative to that released by addition of 1 mM TCEP, which released all of the spin label (Fig. 2) . The result was the same whether the proteoliposomes were PLYEG, PLYEG + SecA, or PLYEG•A. Thus, the orientation of the translocon is random.
Determination of the Number of Active Translocons. The two remaining explanations for the high activity of PLYEG•A are that coassembly of SecA and SecY results in an increase in the number of translocons that are active or in an increase in the turnover rate of each translocon. The data shown in Fig. 1 do not allow one to distinguish between the two because each translocon is likely to be used for more than a single cycle of transfer. To determine the number of translocons that are active in each preparation, we used radiolabeled precursors that contain disulfide-stabilized loops of either 44 or 59 aminoacyl residues near the C termini of pGBP and proOmpA, respectively. Translocation of these precursors is initiated, but stalls at the loop, which cannot pass through the channel in SecY. Incomplete translocation results in inactivation of the SecYEG for additional cycles of transfer (29) . Because partial transfer results in protection of intermediate lengths of precursor polypeptides, the number of translocons that are active and stalled can be determined by quantification of these intermediates. Using conditions in which the concentration of SecYEG was limiting (1 μM; see Fig. S2 for evidence), proteoliposomes to which SecA was added during the assay protected 50 nM proOmpA intermediates and 35 nM pGBP intermediates, whereas PLYEG•A showed protection of 300 nM proOmpA intermediates and 180 nM intermediates of pGBP ( Fig. 3 A and B , compare open and closed circles), indicating an increase of active translocons of approximately sixfold. The activation of SecYEG required that SecA be present during assembly, as incubation of SecA with PLYEG for 2 h at room temperature to mimic the conditions of coassembly showed no significant increase in the number of active translocons (Fig. 3 A and B, triangle). After coassembly, further addition of SecA at the time of the assay is neither required nor inhibits (Fig. S3) . The protected polypeptide species are indeed intermediates stalled in otherwise-active translocons, as addition of DTT after the intermediates had maximally accumulated (Fig. 3C , open symbols) resulted in a reduction of the disulfide bond and the appearance of protected full-length precursors (Fig. 3C, closed symbols) . The increase in the number of active translocons can easily account for the high activity of PLYEG•A; however, it remains possible that the rate constant is also increased. We were not able to obtain initial rates for SecYEG to which SecA was added during the assay because of the low level of activity.
The number of active translocons in native inverted cytoplasmic membrane vesicles was determined for comparison with our reconstituted system. The vesicles were prepared from an E. coli strain expressing SecYEG from the same plasmid as that used to purify SecYEG. The inverted vesicles, assayed under conditions with SecYEG limiting (1 μM SecY), showed a maximal concentration of active translocons of ∼550 nM when assessed with proOmpA, and 310 nM when pGBP was the precursor used. To compare directly these results with the results using proteoliposomes, we expressed our data as the fraction that was active relative to the total accessible SecYEG. Disruption of cells using a French press renders 95% of vesicles inverted (30) , and thus in the vesicles, 950 nM translocons were accessible, whereas 550 nM were accessible in the proteoliposomes (Fig. 2) . When SecYEG alone was reconstituted into proteoliposomes, only 10% of the translocons were active. In contrast, coassembly resulted in recovery of the same fraction of active translocons as that seen in the native membranes (Fig. 4A ). It is of particular interest that in both systems the number of active translocon units jammed when pGBP was being translocated was approximately half of the number seen with proOmpA. The approximate twofold difference was observed reproducibly with proteoliposomes made from several separate purifications of SecYEG, and also with two independent preparations of inverted membrane vesicles made over several years. In each experimental system, the same preparations were used for both precursors; thus, the number of active heterotrimeric units of SecYEG was the same. Therefore, we conclude that translocation of pGBP requires twice the number of units of SecYEG as does translocation of proOmpA.
In the experiments discussed earlier, a single species of precursor was present in each assay. In a different experimental design (Fig. 4B ), the two different precursors, each containing an oxidized loop, were added to the same PLYEG•A. By initiating the translocation of nonradioactive pGBP at the start of the assay, followed by addition of 14 C-proOmpA 1 min later, we demonstrated, as proposed, that pGBP engages two units of SecYEG. In the absence of competing pGBP, 360 nM intermediates of proOmpA accumulated (Fig. 4B , green square), whereas when the translocons had first engaged pGBP, this level was reduced to 53 nM (Fig. 4B , green circle; also see Fig. S4 ). In a parallel experiment in which the pGBP was radiolabeled, 177 nM translocon units were jammed (Fig. 4B , pink triangle). If pGBP were to use only a single unit of SecYEG for each intermediate, then 183 nM SecYEG translocon units (360-177 nM) should have been available for proOmpA. However, only 53 nM were observed, thus supporting the interpretation that pGBP uses two units of SecYEG. If pGBP continuously occupied two units of SecYEG (177 nM × 2 = 354 nM), one would expect none to be free for proOmpA. However, it is possible that the association with one of the units is transient (see Fig. 8 for model), thus accounting for the low level of proOmpA intermediates observed.
SecA Region That Converts SecYEG to Active State. It is unclear whether the ability of SecA to convert SecYEG to an active state is separate from the ability to function in translocation, which involves interactions with the chaperone SecB and precursor polypeptides, as well as the hydrolysis of ATP. To separate these functions, we tested defective variants of SecA: SecA880, which is truncated to remove the C-terminal 21 aminoacyl residues that coordinate zinc; SecAC4, which lacks zinc because the coordinating cysteines are replaced by serine; and SecAdN10, which has aminoacyl residues 2-11 deleted. These variants are defective in binding of SecB and have low activity (Fig. S5 ) because they do not efficiently couple the energy of ATP hydrolysis to the movement of precursors (31) . SecAN664, which is truncated at aminoacyl residue 664, and the two fragments containing only the C-terminal 239 and 282 aminoacyl residues (C662 and C619), are completely inactive in our in vitro translocation assay (Fig. S5) . Each variant species was separately incorporated into PLYEG•A. Because the variant SecA species are themselves defective, to assess the number of active translocons, wildtype SecA was added to each assay. In the presence of wild-type SecA, the number of active translocons observed in the PLYEG•SecA containing the variant species SecA880 (Fig. 5 A and C), SecAC4, and SecAN664 (Fig. 5B ) was similar to that seen with PLYEG•wild-type SecA (Fig. 5 A and C) . The short Cterminal fragments showed no ability to convert SecYEG to an active state (Fig. 5B) , which is consistent with observation that they do not bind SecYEG (32) . The assembly of PLYEG•A using SecAdN10 showed an intermediate level of active translocons compared with the other variants (Fig. 5 A and C) . The simplest explanation is that deletion of 10 residues at the extreme N terminus affects the ability of SecA to associate properly with SecY in lipid, and therefore fewer translocons were converted to the active state. We conclude that full activity in translocation is not required for the ability to activate SecYEG.
Because addition of wild-type SecA to proteoliposomes containing SecYEG only showed very few active translocons (Fig. 3) , it is likely that the wild-type SecA added extraneously to the assay had exchanged with the variant SecA species, which, in fact, had rendered the SecYEG active during the coassembly. We demonstrated that externally added wild-type SecA does replace the variant species and becomes integrated into the membrane. Proteoliposomes PLYEG•SecAdN10 or PLYEG• SecA880, in which the variant SecA species was radiolabeled ( 14 C-pGBP added at t = 0 (pink △), 14 C-proOmpA added at t = 0 (green □), 14 CproOmpA added at t = 1 min following addition of nonradiolabeled pGBP at t = 0 (green ○). These data (green ○) were corrected to take into account loss of activity of the system with time (Fig. S4) . Error bars are SD.
increase in activity (Fig. 6 , compare open and closed circles). The extent of displacement of the radiolabeled species was determined from the quantity of 3 H-SecA released into the supernatant after centrifugation. In the case of PLYEG• 3 H-SecAdN10, 96% ± 8% of the accessible SecA was released after the first centrifugation, and for 3 H-SecA880, 79% ± 3.5% was removed. Therefore, we conclude that the translocation was mediated by wild-type SecA that was isolated with the SecYEG in proteoliposomes after having replaced the defective variant SecA species.
Imaging of SecA Bound to SecYEG by Atomic Force Microscopy. Imaging by atomic force microscopy of liposomes containing only SecYEG showed features with heights above the bilayer that are in agreement with structural data from X-ray crystallography (1, 16) and cryo-electron microscopy (33) (Fig. 7A) . The prominent feature in the height distribution at 32 Å is consistent with the height of the extended 6/7 loop observed in the structures [maximum height of ∼20 Å, Methanocaldococcus jannaschii (1); ∼30 Å, Thermotoga maritima (16); ∼30 Å, E. coli (33) ]. Because the loop is flexible and our data are measurements of single proteins (34) , the feature at 17Å is likely to represent particles in which the loops are collapsed to reveal the ends of the α-helices of TM8 and TM9 that extend above the bilayer. Fig. 7 shows that SecA binds SecYEG in liposomes in two distinct modes. When SecA was added extraneously to liposomes containing SecYEG, the features showed a wide distribution of heights with no prominent peaks (Fig. 7B, brown line) , indicating that SecA populates multiple binding states. In contrast to this broad distribution of heights, the sample of proteoliposomes in which SecY and SecA were co-assembled (PLYEG•A) had predominant species centered at 40 Å (Fig. 7B, red line) . Because these proteoliposomes contain approximately sixfold more active translocons than do the proteoliposomes to which SecA was added after assembly, we conclude that this structural state represents SecA bound to translocons that have been rendered active.
Imaging confirmed that wild-type SecA had replaced SecAdN10 in association with SecYEG in the experiment described earlier (Fig. 6) . The height distribution of PLYEG•SecAdN10 (Fig. 7C) is drastically different from that of PLYEG•wild-type SecA and closely resembles that of PLYEG to which SecA was subsequently added in solution (compare Fig. 7 B, brown with C, green): both show a wide distribution of heights with no prominent peak. After addition of wild-type SecA to the PLYEG•SecAdN10 and reisolation of the proteoliposomes, the height profile was shifted (Fig. 7C, blue) to resemble that of PLYEG•wild-type SecA, with a prominent peak characteristic of the active translocase instead of the distribution typical for PLYEG to which SecA was added.
Discussion
The results presented here suggest that the number of heterotrimeric units of SecYEG that form an active translocase varies with the precursor undergoing transfer. In both reconstituted proteoliposomes and inverted cytoplasmic membrane vesicles, we observed a twofold difference between proOmpA and pGBP. It appears that proOmpA is exported via a single unit of SecYEG, whereas translocation of pGBP engages two units, although at this point we cannot eliminate the formal possibility that the difference is between two units and four. This phenomenon requires further investigation, but it is worth noting not only that OmpA and GBP differ in their final location but also that GBP is more dependent on SecB than is OmpA. Translocation of pGBP has an extreme dependence on SecB both in vivo and in vitro (35) , whereas that of proOmpA is only stimulated.
A working model for translocation of pGBP mediated by a complex between SecA and SecB with two units of heterotrimeric SecYEG can be proposed based on the unusual binding properties of SecA and SecB (Fig. 8) . The complex with maximal efficiency for coupling ATP hydrolysis to translocation of pGBP contains two protomers of SecA bound to a SecB tetramer (Fig.  8, step 1) (31, 36) . The interactions stabilizing this complex map to three different areas (37) . Surprisingly, the binding between the two symmetric molecules is asymmetric. Breaking contact at either one of two of these areas results in dissociation of only one protomer of SecA; the other protomer remains associated to give a complex of one SecA protomer bound to tetrameric SecB (38) . This means that the two protomers of SecA differ in the details of binding to SecB and might play different roles in translocation. Another interesting observation is that SecA binds all of its interacting partners on one surface, using overlapping but not identical binding sites (39) . We propose that there is a dynamic interplay among SecA, SecB, precursor, SecYEG, and lipids that involves the making and breaking of subsites of interaction. The loss of one of the protomers does not change the dissociation constant of the complex as a consequence of enthalpic/entropic compensation (37) . In this way, transfer of the precursor from SecB to SecA, and further to the translocon, could be accomplished without complete dissociation of the complexes. Release of one protomer of SecA might be accompanied by the transfer of a portion of the precursor from SecB to SecA. This protomer of SecA bound to precursor could then bind SecY with the same surface that had been occupied by SecB (Fig. 8, step 2) . The precursor, which had been held at this surface between SecA and SecB (36, 39), would be poised for transfer from SecA into the channel of SecY. The second protomer of SecA bound to SecB and the remainder of the precursor could bind a second idle unit of SecYEG (Fig. 8, step 3) . When the SecA positioned on the active channel releases the precursor and dissociates, the second protomer of SecA, in complex with SecB and the more distal portion of the precursor, could release the SecB and bind the actively translocating SecYEG to continue transfer of the polypeptide (Fig. 8, step 4) . The second SecYEG would now be free to engage another precursor and begin a new cycle. This model is supported by the cleverly designed experiments of Morita and coworkers (40) showing that multiple SecA proteins sequentially engage a single SecYEG to translocate a precursor. The model they present requires only a minor addition to make it consistent with that which we propose here. We have included a nontranslocating SecYEG bound to the second SecA and its associated SecB and stretch of precursor. Further investigation is required to determine why proOmpA is translocated using only one unit of SecYEG.
Our data also address the long-standing question concerning the roles for the various forms of SecA that have been observed. Since the original identification (7), it has been known that SecA is distributed in vivo equally between soluble and membraneassociated states. The cytosolic SecA is involved in capture of newly synthesized precursors, either directly or in complex with SecB, and in delivery to the translocon. Of the membrane-associated SecA, one-third is integrated into the hydrocarbon region of the bilayer (9) . The integral membrane SecA exists in more than one conformation that have different sensitivities to proteases (13) . No function has yet been assigned to either form. Perhaps these differences reflect the different states of SecA revealed in our reconstitution studies: the SecA assembled with SecY and the SecA that binds to SecY from solution. Coassembly of SecYEG and SecA increased the yield of active SecYEG heterotrimers to a level corresponding to that observed in the native environment of inner membrane vesicles. We speculate that this may reflect the in vivo situation in which SecA would always be present during the integration of the three proteins that assemble to make the heterotrimer. Complex formation between SecY and SecA at early stages of SecYEG assembly might shift an equilibrium to favor an active state of SecY that is subsequently stabilized by interaction with the lipid bilayer and the other protein components. The function of SecA during assembly of SecYEG does not require the full translocation ability of SecA. Variant forms defective in translocation rendered SecYEG active. The region of SecA crucial for activation is within the first 664 aminoacyl residues. Further work will more precisely define the critical region. It has been estimated that SecA exists in the cell in a 10-fold molar excess over SecYEG (41) ; thus, all translocons could assemble in the membrane in complex with SecA and leave a large pool of free cytosolic SecA. Once inserted, SecYEG could freely exchange the integrated SecA for soluble SecA. The SecA bound nonspecifically to lipid head groups via the C-domain (10, (42) (43) (44) might also be a source of SecA for exchange. It has been proposed previously that this membrane-bound pool of SecA facilitates binding to translocons as they become available (44) . In this way, all of the identified forms of SecA would participate in the export cycle.
Our method for reconstitution, which yielded a highly active system, might have wider application in the assembly of other membrane complexes in which peripheral subunits cycle off and on the membrane. Many membrane proteins, when removed from the native lipid environment and purified in detergent, exhibit low levels of activity when reconstituted. Perhaps assembly in the presence of binding partners could restore function to other systems.
Methods
For details of all procedures for preparation of proteins, proteoliposomes, and vesicles as well as all assays, see SI Methods. In brief, the crucial factor in making highly active proteoliposomes was simultaneous incorporation of purified SecA and detergent solubilized SecYEG. The lipids used were E. coli polar lipids (Avanti).
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SI Methods
Purification of Proteins. The translocon, SecYEG, was purified from a strain C43(DE3) suitable for overexpression of membrane protein (1) harboring a plasmid encoding secE with a Histag at the N terminus, secYC329S, C385S, and secG (2). Cells were broken by passage through a French pressure cell (8,000 psi), and the membranes were isolated by centrifugation and solubilized in dodecyl-β-maltoside (DBM). SecYEG was purified by chromatography, using a HisTrap column (GE Healthcare), and stored at −80°C in 20 mM Tris-Cl at pH 8, 0.3 M NaCl, 10% (wt/vol) glycerol, 0.6 mM DBM, and 2 mM DTT. SecA ATPase and SecA variants were purified as described (3), with the following modifications: Intact washed cells were incubated on ice for 30 min with 8 mM EDTA to chelate Mg 2+ in the cell envelope. The cells were pelleted and washed twice to remove the EDTA before being lysed by three cycles of freezing and thawing in the presence of lysozyme. The removal of EDTA before lysis is crucial to prevent the extraction of zinc from SecA. After centrifugation, SecA species were purified from the relevant supernatants by chromatography, using QAE (TosoHaas) and/or HiTrap Blue affinity columns (GE Healthcare). The purified proteins were dialyzed into 10 mM Hepes at pH 7.6, 0.3 M potassium acetate (KOAc), 2 mM DTT, and stored at −80°C. Cultures for the chaperone SecB purification were grown as described (4), the cells were disrupted with a French press at 8,000 psi, and the protein was purified from high-speed supernatants, using a QAE column (TosoHaas). The purified SecB was stored in the same solution as that used for SecA. Concentrations of the proteins were determined spectrophotometrically at 280 nm, using coefficients of extinction as follows: SecB tetramer, 47,600 M −1 ·cm −1 ; SecA wild-type and SecAdN10 monomers, 78,900 M −1 ·cm −1 ; SecA880, 77,200 M −1 ·cm −1 ; and SecYEG, 45,590 M −1 ·cm −1 . SecAdN10 has aminoacyl residues 2 though 11 deleted and SecA880 is truncated to remove the C-terminal 21 aminoacyl residues that coordinate zinc.
Preparation of Radiolabeled Proteins. The precursors of outer membrane protein A (OmpA) and periplasmic galactose-binding protein (GBP) were produced from plasmids (pAL612 and pAL663, respectively) carrying the ompA gene or the mglB gene altered to generate polypeptides with only two cysteine residues. In OmpA, C290 was substituted by serine and G244 by cysteine, and the native C302 was retained. For GBP, two cysteines were introduced, L267C and D310C. The proteins were radiolabeled by the addition of [ C-L-amino acids (Perkin-Elmer) to cells growing in M9 minimal media, as described (5). Precursor OmpA (proOmpA) was purified as described (5). Precursor GBP (pGBP) was purified as follows: cells were disrupted with a French press, inclusion bodies containing pGBP were collected by centrifugation, solubilized with urea, and loaded onto a HiTrap QAE column (GE Healthcare). Precursors were stored at −80°C in 10 mM Hepes at pH 7.6 with 1 mM tris(2-carboxyethyl)phosphine (TCEP) to maintain the sulfhydryls in reduced form; for proOmpA, 0.1 M KOAc and 4 M urea; and for pGBP, 0.3 M KOAc, 1 N GnHCl, and 1 mM EGTA. Disulfide bond-stabilized loops were generated after removal of TCEP by the addition of 0.1 mM copper phenanthrolene to the solution and incubation for 5 min on ice. Copper phenanthrolene was removed using a NAP10 column (GE Healthcare). Unilamellar liposomes were prepared by extrusion of Escherichia coli (E. coli) polar lipids (Avanti) suspended in 10 mM Hepes at pH 7.6, 30 mM KOAc, 1 mM Mg(OAc) 2 through membranes with a 100-nm pore diameter, using a Liposofast (Avestin). To form proteoliposomes, the liposomes were swelled but not disrupted, using a ratio of detergent to lipids of 4.65 mM DBM to 5 mM lipids (6) . After swelling for 3 h at room temperature, the proteins to be incorporated were added: SecYEG at 5.2 μM, and for coassembly of SecA, SecA at 5 μM dimer unless otherwise specified. Incubation was continued for 1 h at room temperature, followed by addition of BioBeads SM-2 (BioRad) to remove the detergent. The proteoliposomes were isolated by centrifugation at 436,000 × g, 20 min at 4°C, in a TL100.1 rotor (Beckman). The pellet was suspended in the same buffer and centrifuged again as earlier. The final pellet was suspended to give a concentration of ∼10 mM lipid and 10 μM SecY. The suspension was stored at −80°C.
Inverted membrane vesicles were prepared from a strain harboring the same plasmid as used for purification of SecYEG. The strain was the same as for purification except that ΔuncBC was introduced to eliminate the proton-translocating ATPase. The cells were disrupted using a French press (8,000 psi), and the cytoplasmic membrane (density 1.14-1.18 g·mL −1 ) was purified by equilibrium density gradient centrifugation (7).
Determination of Orientation of SecYEG in Proteoliposomes. SecYEG with a single cysteine introduced at residue 255, R255C, was labeled with the nitroxide reagent (1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)-methanethiosulfonate (Toronto Research Chemicals), as described (8), and the spin-labeled SecYEG was assembled into liposomes alone or with SecA. Samples of 8 μL containing spinlabeled proteoliposomes YEG (PLYEG) or spin-labeled proteolipsomes YEG·SecA (PLYEG·A) at ∼40 μM spin-labeled SecYEG and 40 μM SecA dimer, if included, were loaded into synthetic silica capillaries. Spectra were acquired over a period of 100 min. The samples were proteoliposomes with no addition and proteoliposomes to which 50 μM TCEP was added at the start, followed after 71 min by further addition of TCEP to 1 mM. Electron paramagnetic resonance (EPR) spectroscopy was performed on an X-band Bruker EMS spectrometer with an ER 4123D dielectric resonator. Fifteen scans were recorded for each spectrum using incident microwave power at 20 mW and a 100-kHz field modulation of 1 G. The increase in the amplitude of the center line over the amplitude of the line in the absence of TCEP as a function of time was used as a measurement for the release of free spin. Free spin has a well-characterized line shape comprising very sharp spectral lines and is readily distinguishable from spin attached to a protein, which is less mobile and therefore exhibits broader spectral lines. with SecA (1.2 μM dimer), SecB (1 μM tetramer), and EGTA (1 mM) to prevent pGBP from folding, as described (5), with the following modifications: An ATP-regenerating system consisting of 7.5 mM phosphocreatine and 37 mg/mL of creatine phosphokinase was present in the reaction. The precursors are stored in denaturant (4 M urea for proOmpA or 1 N GnHCl for pGBP) and diluted into the translocation assay, which thus contains either 44 mM urea or 11 mM GnHCl. In experiments using precursors containing internal disulfide bonded loops, DTT was omitted from the reaction mix. Proteinase K (5 units/mL, 15 min on ice) was used for degradation of untranslocated proteins, and digestion terminated by trichloroacetic acid precipitation. The washed precipitate was dissolved in gel sample buffer containing DTT (10 mM) for analysis by electrophoresis.
Analyses of Translocation Data. The radioactivity in the protein bands in the gels of the translocation assays was measured using a Fujifilm FLA 3000 phosphorimager in the linear range of its response. For the experiments in which the number of active translocon units was determined, the radioactive precursors used contained internal disulfide bonded loops. When oxidized precursors were used as substrates, the protected protein intermediates observed spanned molecular weight ranges of 23.8-30.5 kDa (full length, 37.2 kDa) for proOmpA and 28.8-31.7 kDa (full length, 35.7 kDa) for pGBP. Only species that could be converted to full-length precursors after reduction of the disulfide bond in the loop were included in the estimate of the molarity of the intermediates. We assumed that all protected bands were N-terminal fragments of the precursor, estimated their lengths from a standard curve derived from the molecular weight markers on the gel, and corrected for the missing 14 C-labeled sequences or missing [ 35 S]methionines to calculate the molarity. To determine molarity of the full-length precursors and the intermediate-length species protected from degradation by proteinase K, samples of the reaction mixture were taken at t = 0 min and processed without addition of protease. The t = 0 sample was taken in duplicate, as this value was the basis for calculation of molarity for each point in the time course. H-Met) variant SecA species. The ratio during coassembly for SecAdN10 was 5 μM SecA dimer to 5.2 μM SecY, and for SecA880, 2.5 μM dimer to 5.2 μM SecY. Exchange of wild-type SecA for the incorporated variant species was achieved by incubation of the proteoliposomes at 30°C for 5 min in 10 mM Hepes at pH 7.6, 250 mM KOAc, and 5 mM Mg(OAc) 2 with wild-type SecA at either an equal concentration to that of SecA in the proteoliposomes for SecAdN10 or an eightfold molar excess for SecA880. The proteoliposomes underwent 3 cycles of centrifugation (Beckman TL100.1 rotor at 436,000 × g, 4°C, 15 min) and suspension to remove soluble SecA before they were assayed for the number of active translocons at 1 μM SecY and 1 μM oxidized proOmpA. The amount of variant 3 H-SecA displaced was determined by liquid scintillation counting of samples of the supernatant fractions after each centrifugation and of the final pellet. Because the radiolabel on SecA was 3 H, which is not detected by the phosphorimager, it did not interfere with the assay of activity using 14 C-and 35 S-labeled precursors.
Imaging by Atomic Force Microscope. Samples for imaging were PLYEG only, PLYEG to which 8 μM SecA dimer was added to 8 μM SecY, and PLYEG·A. The samples were diluted to 80 nM SecYEG in imaging buffer [10 mM Hepes at pH 7.6, 100 mM KOAc, 5 mM Mg(OAc) 2 ] and immediately deposited on a freshly cleaved mica surface (Ted Pella) and incubated for ∼20 min at ∼30°C. The samples were then rinsed three times with 100 μL imaging buffer. Images of atomic force microscope were acquired in imaging buffer in tapping mode, using a commercial instrument (Cypher, Asylum Research) and Biolever mini tips (BL-AC40TS, Olympus) with spring constants ∼0.06 N/m. Images were recorded at ∼30°C with an estimated tip-sample force of ∼100 pN, deduced by comparing the free space tapping amplitude (∼5 nm) with the imaging set point amplitude (∼4 nm). Under such conditions, minimal protein distortion is expected (9, 10).
Concentration of Protein and Lipid. The concentrations of the radiolabeled precursors were determined using SDS polyacrylamide electrophoresis and comparing the intensity of the protein bands with those of standards run on the same gel. The concentration of proteins used as standards was determined by amino acid composition of proteins having purities of greater than 95%. The concentration of purified SecY, as for the other proteins, was determined by SDS polyacrylamide electrophoresis and a standard run on the same gel. For inner membrane vesicles, the concentration of SecY was determined using a Western blot. The intensity of bands was quantified using TotalLab Software. The concentration of lipids was determined as described on the Avanti Polar Lipids Web site (www.avantilipids.com), using an average molar mass for E. coli lipids of 741 Da. SecAN664 comprises aminoacyl residues 1 through 664. Truncation at residue 664 results in removal of the last 4 residues of the helix scaffold domain, the entire helical wing domain, two helix fingers, and the extreme C-terminal domain, which contains the zinc binding site. Fig. S2 . SecYEG is limiting. PLYEG•wild-type SecA were assayed for number of active translocons, using the oxidized forms of proOmpA (•) and pGBP (○). The precursors and SecB were held constant, at 1 μM each, and the concentration of SecY was varied between 0.7 and 2.4 μM, as indicated. Because the amount of protected precursor intermediates, representing active translocons, increases linearly with the increase of PLYEG•A up to 1.4 μM, it can be concluded that under the conditions used for the experiments in this study (i.e., PLYEG•A at 1 μM SecY, 1 μM precursor, and 1 μM SecB), the system is limited by SecY and not by precursor or SecB. Linearity falls off between 1.4 and 2.4 μM, and yet at all concentrations tested, the ratio between units jammed by proOmpA and units jammed by pGBP (red △) is constant at 2.0. 
